1- Durak H, Uğur Ö, Öztürk F. Giant rhabdomyosarcoma with necrosis visualized with thallium-201 chloride. Clin Nucl Med 1991; 16: 947-948.

2- Caner B, Kitapçı M, Aras T, Erbengi G, Uğur Ö, Bekdik C. Increased accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in osteosarcoma and its metastatic lymp nodes. J Nucl Med 1991;32:1977-1979.

3- Erbaş B, Arınsoy T, Uğur Ö, Varoğlu E, Arık N, Bekdik C. Uterine technetium-99m mercaptoacetyltriglycine and diethylene triamine penta-acetic acid uptake in the scintigraphic evaluation of transplanted kidneys. Eur J Nucl Med 1992; 19:375-377.

4- Özdemir O, Erbaş B, Uğur Ö, Varoğlu E, Erbengi G, Bekdik C, Oram E. Scintigraphic evaluation of the short and long term renal effects of oral felodipine using technetium-99m-mercaptoacetyltriglycine. Am J Nephrol 1993; 13: 249-254.

5- Erbaş B, Özdemir O, Pasaoğlu İ, Uğur Ö, Varoğlu E, Koray Z, Yorgancıoğlu C, Hazan E, Oram E, Bekdik C. Short and long term effects of felodipine on circulating endothelin and atrial natriuretic peptide levels in essential hypertension. Nephron 1993; 63:363-364.

6- Uğur Ö, Caner B, Balbay MD, Özen HA, Remzi D, Ulutuncel N, Bekdik C. Bleomycin lung toxicity detected by technetium-99m diethylene triamine penta-acetic acid aerosol scintigraphy. Eur J Nucl Med 1993; 20: 114-118.

7- Caner B, Uğur Ö, Bayraktar M, Ulutuncel N, Menteş T, Telatar F, Bekdik C. Impaired lung epithelial permeability in diabetics detected by technetium-99m-DTPA aerosol scintigraphy. J Nucl Med 1994; 35: 204-206.

8- Uğur Ö, Scott AM, Kostakoğlu L, Hui TE, Masterson ME, Febo R, Sgouros G, Rosa E, Mehta BM, Fisher DR, Cheung NKV, Larson SM. Calculated and TLD-based absorbed dose estimates for I-131 labeled 3F8 monoclonal antibody in a human neuroblastoma xenograft nude mouse model. Nucl Med Biol 1995; 22: 87-93.

9- Kostakoğlu L, Uğur Ö, Cheung N-K.V, Zhang J, Huang Y, Larson SM. Quantitative autoradiography to determine local GD2 antigen concentration of a human neuroblastoma xenograft growing in nude mice using monoclonal antibody 3F8. Antibody Immunoconj Radiopharm. 1995; 8: 145-154.

10- Uğur Ö, Kostakoğlu L, Hui TE, Fisher DR, Garmestani K, Gansow OA, Cheung N-K.V, Larson SM. Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma: Dosimetry calculations incorporating cross organ beta doses. Nucl Med Biol 1996; 23: 1-8.

11- Uğur Ö, Kostakoğlu L, Caner B, Güler N, Gülaldı NCM, Özmen M, Uysal U, Elahi N, Erbengi G, Bekdik C. Comparison of Tl-201, Tc-99m-MIBI and I-131 imaging in the follow up of patients with well differentiated thyroid carcinoma. Nucl Med Commun 1996; 17:373-377.

12- Uğur Ö, Caner B, Çekirge S, Balkancı F, Ergün E.L, Kostakoğlu L, Aras T, Bekdik C. Tc-99m-ethylenedicysteine in the diagnosis and follow-up of renovascular hypertension. Invest Radiol 1996; 31:378-381.

13- Uğur Ö, Peksoy İ, Caner B, Çekirge S, Balkancı F, Bekdik C. Renovascular hypertension due to Takayasu arteritis demonstrated by Tc-99m-ethylenedicysteine captopril scintigraphy. Clin Nucl Med 1996; 21: 714-716.

14- Uğur Ö, Kostakoğlu L, Güler N, Caner B, Uysal U, Elahi N, Haliloğlu M, Yüksel DG, Aras T, Bayhan H, Bekdik C. Comparison of Tc-99m(V)-DMSA, Tl-201 and Tc-99m-MIBI imaging in the follow up of patients with medullary carcinoma of the thyroid. Eur J Nucl Med 1996; 23: 1367-1371.

15- Uğur Ö, Caner B, Bakkaloğlu M, Ergün EL, Toklu C, Ahmadi MK, Bekdik C. Segmental ATN in a kidney with a single artery transplanted from living related donor. Nuclearmedizin 1996; 35:190-192.

16- Uğur Ö, Caner B, Çekirge S, Balkancı F, Ergün EL, Kostakoğlu L, Bekdik C. The diagnosis of renovascular hypertension with technetium-99m-ethylenedicysteine captopril scintigraphy. Invest Radiol 1996; 31:497-501.

17- Kostakoğlu L, Uysal U, Özyar E, Elahi N, Hayran M, Uzal D, Demirkazık FB, Kars A, Uğur Ö, Atahan L, Bekdik CF. Pre-and post-therapy Thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma. J Nucl Med 1996; 37: 1956-1962.

18- Caner B, Rezaghi C, Uysal U, Tokgözoğlu L, Elahi N, Kes S, Aras T, Ugur O, Bekdik C. Dobutamine thallium-201 myocardial SPECT in patients with left bundle branch block and normal coronary arteries. J Nucl Med 1997; 38: 424-427.

19-Caner B, Karanfil A, Uysal U, Tokgözoğlu L, Aksoyek S, Ugur O, Çiftçi İ, Atalar E, Kes S, Bekdik C. Effect of an additional atropine injection during dobutamine injection for myocardial SPET. Nucl Med Commun 1997; 18:567-573.

20- Uğur Ö, Peksoy İ, Caner B. Technetium-99m-ethylenedicysteine: An alternative agent to detect renovascular hypertension. J Nucl Med 1997; 38: 1662-1664.

21- Onur O, Celiker R, Cetin A, Alikasifoglu A, Ugur O, Basgoze O. Hypophosphatemic rickets with sacroiliitis-like presentation in an adolescent. Scand J Rheumatol 1997; 26: 332-335.

22-Peksoy İ, Ergün EL, Uğur Ö, Caner B. Ghost appearance in dacryoscintigraphy. J Nucl Med 1998; 39: 2189.

23- Uğur Ö, Serdengeçti M, Karacalioğlu Ö, Peksoy İ, Çekirge S, Aslan N, Ergün EL, Duranay M, Yurdakul M, Caner B, Bayhan H. Comparison of Tc-99m-EC and Tc-99m-DTPA captopril scintigraphies for the diagnosis of renal artery stenosis. Clin Nucl Med 1999; 24:553-560.

24- Uğur Ö, Serdengeçti M, Karacalioğlu Ö, Ergün EL, Peksoy İ, Çekirge S. Prediction of response to revascularization in patients with renal artery stenosis by Tc-99m-ethylenedicysteine captopril scintigraphy. Ann Nucl Med 1999; 13: 77-81.

25- Yüksel D, Ilgan S, Arslan N, Uğur Ö, Öztürk E, Bayhan H. The role of Tc-99m (V) DMSA scintigraphy in the evaluation of superscan on bone scintigraphy. Clin Nucl Med 2000; 25: 193-196.

26-Bozkurt MF, Uğur Ö. Assessment of penile bone graft viability by bone scintigraphy: a case report. Ann Nucl Med 2000;14:377-8.

27- Sarı O, Uğur Ö, Emir S, Akyüz C. Combined use of chemotherapy and 131I-metaiodobenzylguanidine in the treatment of advanced stage neuroblastoma. The Turk J Pediatr. 2001;43:29-33.

28- Ergün EL, Çağlar M, Erdem Y, Usalan C, Uğur Ö, Duranay M. Tc-99m-DTPA acetylsalicyclic acid (aspirin) renography in the detection of renovascular hypertension. Clin Nucl Med 2000;25:682-690.

29- Bozkurt MF, Uğur Ö. Intra-arterial Tc-99m-MDP injection mimicking reflex sympathetic dystrophy. Clin Nucl Med 2001; 26:154-6

30- Bozkurt MF, Uğur Ö, Ertenli I, Caner B. Combined use of bone and bone marrow scintigraphies for the diagnosis of active sacroiliitis: A new approach. Ann Nucl Med 2001;15:117-21

31- Arslan N, Ilgan S, Yüksel D, Serdengeçti M, Bulakbasi N, Uğur Ö, Özguven MA. Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery. Clin Nucl Med 2001; 26:683-8

32- Uğur Ö, Kothari PJ, Finn RD, Zanzonico P, Ruan S, Guenther I, Maecke HR, Larson SM. Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors. Nucl Med Biol 2002; 29: 147-157.

33-Uğur Y, Sarı O, Uğur Ö, Korkusuz P, Varoğlu E, Arslan N, Gürcan N, Yıldırım M, Sökmensüer C, Aşan E, Aras T. Lack of correlation between Tc-99m-sestaMIBI uptake and cadherin expression in infiltrating ductal breast carcinoma as prognostic indicators. Ann Nucl Med 2003: 17; 281-287.

34-Bozkurt MF, Uğur Ö. A new scintigraphic method for the diagnosis of active sacroileitis: Combined use of bone and bone marrow scintigraphy. Medical Imaging International. 2002; 12: 11-12.

35- Bozkurt MF, Uğur Ö, Hamaloğlu E, Sayek İ, Güleç S. Optimization of the gamma probe guided parathyroidectomy. Am Surg 2003; 69: 720-725.

36- Gedik GK, Ugur O, Atilla B, Dundar S. Is corticosteroid coinjection necessary for radiosynoviorthesis of patients with hemophilia? Clin Nucl Med. 2004;29: 538-41.

37- Ugur O, Bozkurt MF, Hamaloglu E, Sokmensuer C, Etikan I, Ugur Y, Sayek I, Gulec SA. Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy. Arch Surg 2004;139:1175-9.

38- Gunay EC, Ozturk MH, Ergun EL, Altun B, Salanci BV, Ugur O, Cil B, Hekimoglu B, Caner B. Losartan renography for the detection of renal artery stenosis: comparison with captopril renography and evaluation of dose and timing. Eur J Nucl Med Mol Imaging. 2005; 5: 1064-74.

39-Mumcuoğlu EU, Nar F, Yardımcı Y, Koçak U, Ergun EL, Salancı BV, Ugur O, Erbaş B. Simultaneous surface registration of ictal and interictal SPECT and magnetic resonance images for epilepsy studies. Nucl Med Commun 2006; 27: 45-55.

40-Ugur O, Kara PO, Bozkurt MF, Hamaloğlu E, Tezel GG, Salancı BV, Karabulut E, Sayek İ. In vivo characterisation of parathyroid lesions by use of gamma probe: comparison with ex vivo count method and frozen section results. Otolaryngol Head Neck Surg 2006; 134: 316-320.

41- Gedik GK, Ugur O, Atilla B, Pekmezci M, Yıldırım M, Seven B, Varoğlu E. Comparison of extraarticular leakage values of radiopharmaceuticals used for radionuclide synovectomy. Ann Nucl Med 2006; 20: 183-188.

42- Tuncel M, Aydın D, Yaman E, Tazebay UH, Güç D, Doğan AL, Taşbasan B, Uğur Ö. The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake. Cancer Biother Radiopharm. 2007;22:281-8.

43-Ozyar E, Gultekin M, Alp A, Hascelik G, Ugur O, Atahan IL. Use of plasma Epstein-Barr virus DNA monitoring as a tumor marker in follow-up of patients with nasopharyngeal carcinoma: preliminary results and report of two cases. Int J Biol Markers 2007: 22; 194-199.

44- Ugur O, Bozkurt MF, Rubello D. Nuclear medicine techniques for radio-guided surgery of hyperparathyroidism. Minerva Endocrinol 2008: 14; 95-104.

45- Uğur O, Gedik GK, Atilla B, Rubello D. Radiosynovectomy: current status in the management of arthritic conditions. Nucl Med Commun. 2008;29:755-8.

46- Kara PP, Ayhan A, Caner B, Gültekin M, Ugur O, Bozkurt MF, Usubutun A. Sentinel lymph node detection in early stage cervical cancer: a prospective study comparing preoperative lymphoscintigraphy, intraoperative gamma probe, and blue dye. Ann Nucl Med. 2008: 22; 487-94.

47- Bozkurt MF, Uğur O, Banti E, Grassetto G, Rubello D. Functional nuclear medicine imaging of medullary thyroid cancer. Nucl Med Commun. 2008;29:934-42.

48- Gedik GK, Bozkurt FM, Ugur O, Grassetto G, Rubello D. The additional diagnostic value of a single-session combined scintigraphic and ultrasonographic examination in patients with thyroid and parathyroid diseases. Panminerva Med. 2008;50:199-205.

49- Hindié E, Ugur O, Fuster D, Odoherty M, Grassetto G, Ureña P, Kettle A, Gulec SA, Pons F, Rubello D. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009: 36; 1201-1216.

50- Kara PP, Ayhan A, Caner B, Gultekin M, Ugur O, Bozkurt MF, Usubutun A, Uner A. Analysis of dendritic cells in sentinel lymph nodes of patients with endometrial and patients with cervical cancers. Int J Gynecol Cancer. 2009;19:1239-43.

51- Peynircioğlu B, Cil B, Bozkurt F, Aydemir E, Uğur O, Balkanci F. Radioembolization for the treatment of unresectable liver cancer: initial experience at a single center. Diagn Interv Radiol. 2010;16:70-8.

52-Mumcuoğlu EÜ, Bozkurt FM, Aslan M, Şener E, Uğur Ö. Computerized scar detection on renal cortical scintigraphy images. Nucl Med Commun. 2011;32:1070-8.

53-Caglar M, Bozkurt FM, Akca CK, Vargol SE, Bayraktar M, Ugur O, Karaağaoğlu E. Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer. Nucl Med Commun. 2012;33:268-74.

54-Silindir M, Erdoğan S, Özer AY, Doğan AL, Tuncel M, Uğur Ö, Torchilin VP. Nanosized multifunctional liposomes for tumor diagnosis and molecular imaging by SPECT/CT. J Liposome Res. 2013;23:20-7.

55-Volkan-Salanci B, Sahin F, Babekoğlu V, Uğur O. Experience with nuclear medicine information system. Mol Imaging Radionucl Ther. 2012; 21:97-102.

56-Volkan-Salancı B, Bozkurt MF, Peynircioğlu B, Cil B, Uğur O. The relation between perfusion pattern of hepatic artery perfusion scintigraphy and response to y-90 microsphere therapy. Mol Imaging Radionucl Ther. 2013; 22:98-102.

57-Koçyiğit Deveci E, Ocak M, Bozkurt MF, Türker S, Kabasakal L, Uğur O. The Diagnostic Efficiency of 99mTc-EDDA/HYNIC-Octreotate SPECT-CT in Comparison with 111In-Pentetrotide in the Detection of Neuroendocrine Tumour. Mol Imaging Radionucl Ther 2013; 22: 76-84.

Completed Projects

1- Meme kanserinde Tc-99m-MIBI sintimammografi bulgularının hücre adezyon moleküllerinin immünohistokimyasal ekspresyonları, morfometrik özellikler ve prognoz ile korelasyonu. (Proje yürütücüsü: Dr. Esin Aşan, Hacettepe Üniversitesi Bilimsel Araştırma Birimi proje no: 98.02.101.014)

2- Osteoartritte insülin like growth faktör, insülin, growth hormon düzeyleri, osteoartrit şiddeti ile ilişkisi ve kemik sintigrafisinin prediktif rolü. (Proje yürütücüsü: Dr. Reyhan Çeliker, Tübitak proje no: SBAG-1646)

3- Meme kanserli hastalarda intraoperatif gama probe ve mavi boya tekniklerinin nöbetçi lenf nodunun belirlenmesinde kullanılmasının karşılaştırılması. (Proje yürütücüsü: Dr. Ömer Uğur Hacettepe Üniversitesi Bilimsel Araştırma Birimi proje no: 00 01 101 011).

4- Paratiroid Adenomlarına Cerrahi Yaklaşımda Tc99m-MIBI Sintigrafisi ve İntraoperatif Gamma Prob Uygulaması ( Proje yürütücüsü: Dr. Ömer Uğur Hacettepe Üniversitesi Bilimsel Araştırma Birimi proje no: 02 T05 101 002)

5- Üç boyutlu beyin görüntüsü işleme. ODTU-AFP. Proje yürütücüsü: Dr. Erkan Mumcuoğlu. (ODTÜ Proje no: BAP-2002-07-04-03)

6- İntraartiküler radyonüklid sinovektomi. (Hacettepe Üniversitesi Bilimsel Araştırma Birimi güdümlü proje no: 03-G-024) Proje yürütücüsü: Dr. Ömer Uğur

7- Paratiroid adenomarında Tc-99m-MIBI tutulumunun p-gkoprotein, membranla ilişkili direnç proteini (MRP) ve kromagranin A ekspresyon düzeyi ile ilişkisinin araştırılması. Proje yürütücüsü: Dr. Ömer Uğur (TÜBİTAK Proje no: SBAG-AYD-418 (102S285))

8- Nükleer Tıp Anabilim Dalı dijital arşiv ve PACS entegrasyon. (Hacettepe Üniversitesi Bilimsel Araştırma Birimi güdümlü proje no: 03-G-013) Proje yürütücüsü: Dr. Belkıs Erbaş

9- Differansiye tiroid kanserlerinde I-131 tüm vücut tarama sintigrafisi. (Hacettepe Üniversitesi Bilimsel Araştırma Birimi güdümlü proje no: 03-G-) Proje yürütücüsü: Dr. Biray Caner

10- Tümöral ve normal tiroid hücrelerinde iki farkı TSH stimülasyon yönteminin ve retinoik asit, trikostatin A uygulamasının NIS, TPO, Tg mRNA seviyeleri üzerindeki karşılaştırmalı etkisinin araştırılması Proje yürütücüsü: Dr. Ömer Uğur (TÜBİTAK Proje no: SBAG-2771)

11- Erken evre endometriyum kanserli hastalarda sentinel nod spatanması: Sentinel ve nonsentinel lenf nodlarında dendritik hücre matürasyonunun karşılaştırılması Proje yürütücüsü: Dr. Biray Caner (TÜBİTAK Proje no: SBAG HD22)

High School	TED Ankara Koleji 1983
Univercity	Hacettepe Üniversitesi İngilizce Tıp Fakültesi 1989
Academic Background	Postgraduate / Specialty / Hacettepe Üniversitesi Tıp Fakültesi Nükleer Tıp 1995
Foreign Experience / Education	He carried out some studies in 1992 and 2001 for 2 years in total at Memorial Sloan-Kettering Cancer Center in New York, USA.

:

: